Aptinyx Depreciation & Amortization 2011-2026 | APTX

Annual Depreciation & Amortization Aptinyx

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
122 K	526 K	421 K	455 K	457 K	405 K	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
526 K	122 K	398 K

Quarterly Depreciation & Amortization Aptinyx

2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
32 K	-	119 K	-	38 K	-	488 K	100 K	412 K	-	316 K	211 K	108 K	-	345 K	100 K	117 K	-	100 K	100 K	103 K	-	100 K	100 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
488 K	32 K	170 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Alector ALEC	5.72 M	$ 2.08	-14.4 %	$ 214 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Altimmune ALT	238 K	$ 4.2	-2.67 %	$ 298 M	USA
Apellis Pharmaceuticals APLS	1.56 M	$ 20.24	-3.44 %	$ 2.55 B	USA
Aptorum Group Limited APM	1.13 M	$ 0.8	1.87 %	$ 4.36 M	China
Aprea Therapeutics APRE	7.05 K	$ 0.88	-3.72 %	$ 3.18 M	USA
Aptevo Therapeutics APVO	352 K	$ 7.2	-1.64 %	$ 1.99 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Aquestive Therapeutics AQST	718 K	$ 4.1	2.37 %	$ 356 M	USA
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Arcturus Therapeutics Holdings ARCT	3.54 M	$ 8.35	1.46 %	$ 225 M	Israel
Ardelyx ARDX	3.06 M	$ 6.37	-2.75 %	$ 1.54 B	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Armata Pharmaceuticals ARMP	972 K	$ 10.91	1.58 %	$ 394 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 25.33	-6.1 %	$ 3.22 B	USA
Artelo Biosciences ARTL	500	$ 1.15	-3.36 %	$ 2.32 M	USA
Arvinas ARVN	3 M	$ 12.97	-2.3 %	$ 920 M	USA
Arrowhead Pharmaceuticals ARWR	22.2 M	$ 61.74	-2.42 %	$ 8.26 B	USA
Actinium Pharmaceuticals ATNM	197 K	$ 1.17	-0.85 %	$ 35.2 M	USA
Atossa Therapeutics ATOS	23 K	$ 4.39	-0.9 %	$ 553 M	USA
Atara Biotherapeutics ATRA	5.05 M	$ 5.01	-7.47 %	$ 37.5 M	USA
Aurinia Pharmaceuticals AUPH	19.4 M	$ 14.14	-0.21 %	$ 1.9 B	Canada
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Autolus Therapeutics plc AUTL	7.55 M	$ 1.68	-1.75 %	$ 429 M	Britain
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Atea Pharmaceuticals AVIR	416 K	$ 4.69	0.21 %	$ 395 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Anavex Life Sciences Corp. AVXL	1.25 K	$ 4.54	2.44 %	$ 387 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Axon Enterprise AXON	48.4 M	$ 570.5	5.18 %	$ 43.2 B	USA
Axsome Therapeutics AXSM	503 K	$ 162.28	-0.98 %	$ 8.07 B	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Aytu BioScience AYTU	5.38 M	$ 2.56	-0.58 %	$ 16.1 M	USA
Aileron Therapeutics ALRN	63 K	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA